205 related articles for article (PubMed ID: 36128207)
21. Caffeine and rolipram affect Smad signalling and TGF-β1 stimulated CTGF and transgelin expression in lung epithelial cells.
Fehrholz M; Speer CP; Kunzmann S
PLoS One; 2014; 9(5):e97357. PubMed ID: 24828686
[TBL] [Abstract][Full Text] [Related]
22. TGF-β/Smad signaling in kidney disease.
Lan HY; Chung AC
Semin Nephrol; 2012 May; 32(3):236-43. PubMed ID: 22835454
[TBL] [Abstract][Full Text] [Related]
23. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
Lan HY
Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
[TBL] [Abstract][Full Text] [Related]
24. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Li Z; Hong Z; Peng Z; Zhao Y; Shao R
Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
[TBL] [Abstract][Full Text] [Related]
25. Regulation of TGF-β1-Induced Pro-Apoptotic Signaling by Growth Factor Receptors and Extracellular Matrix Receptor Integrins in the Liver.
Ozaki I; Hamajima H; Matsuhashi S; Mizuta T
Front Physiol; 2011; 2():78. PubMed ID: 22028694
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
Yang J; Zhang X; Li Y; Liu Y
J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
[TBL] [Abstract][Full Text] [Related]
27. Transforming Growth Factor-Beta1 in Diabetic Kidney Disease.
Zhao L; Zou Y; Liu F
Front Cell Dev Biol; 2020; 8():187. PubMed ID: 32266267
[TBL] [Abstract][Full Text] [Related]
28. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.
Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313
[TBL] [Abstract][Full Text] [Related]
29. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.
Xie X; Gan H; Tian J; Li F; Chen J; Wang J; Liao J; Li S
Eur J Clin Invest; 2022 Aug; 52(8):e13791. PubMed ID: 35441708
[TBL] [Abstract][Full Text] [Related]
30. Cytokine receptor-like factor 1 (CRLF1) promotes cardiac fibrosis via ERK1/2 signaling pathway.
Luo S; Yang Z; Chen R; You D; Teng F; Yuan Y; Liu W; Li J; Zhang H
J Zhejiang Univ Sci B; 2023 Aug; 24(8):682-697. PubMed ID: 37551555
[TBL] [Abstract][Full Text] [Related]
31. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
33. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
Gong Y; Yang Y
Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
[TBL] [Abstract][Full Text] [Related]
34. The transforming growth factor beta 1/SMAD signaling pathway involved in human chronic myeloid leukemia.
Su E; Han X; Jiang G
Tumori; 2010; 96(5):659-66. PubMed ID: 21302608
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-140-5p Mediates Renal Fibrosis Through TGF-β1/Smad Signaling Pathway by Directly Targeting TGFBR1.
Liao W; Liang P; Liu B; Xu Z; Zhang L; Feng M; Tang Y; Xu A
Front Physiol; 2020; 11():1093. PubMed ID: 33013464
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-β signalling pathway in tendon healing.
Li Y; Liu X; Liu X; Peng Y; Zhu B; Guo S; Wang C; Wang D; Li S
Growth Factors; 2022 Aug; 40(3-4):98-107. PubMed ID: 35707986
[TBL] [Abstract][Full Text] [Related]
37. Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.
O'Donovan HC; Hickey F; Brazil DP; Kavanagh DH; Oliver N; Martin F; Godson C; Crean J
Biochem J; 2012 Jan; 441(1):499-510. PubMed ID: 21871016
[TBL] [Abstract][Full Text] [Related]
38. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-411-3p inhibits bleomycin-induced skin fibrosis by regulating transforming growth factor-β/Smad ubiquitin regulatory factor-2 signalling.
Zhang Z; Gao X; He Y; Kang Y; Jin F; Li Y; Li T; Wei Z; Li S; Cai W; Mao N; Wang S; Liu H; Yang F; Xu H; Yang J
J Cell Mol Med; 2021 Dec; 25(24):11290-11299. PubMed ID: 34783198
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy with DHA and BMSCs suppressed podocyte injury and attenuated renal fibrosis by modulating the TGF-
Li Y; Chen S; Tan J; Zhou Y; Ren M; Zhang Q; Zhao M; Yuan G; Zhang W; Yang F
Ren Fail; 2023 Dec; 45(1):2120821. PubMed ID: 36648018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
